- Home
- Publications
- Publication Search
- Publication Details
Title
Update on Neurological Manifestations of HTLV-1 Infection
Authors
Keywords
HTLV-1-associated myelopathy/tropical spastic paraparesis, HTLV-1, Myelopathy, Myelitis, Polymyositis, Polyneuropathy
Journal
Current Infectious Disease Reports
Volume 17, Issue 2, Pages -
Publisher
Springer Nature
Online
2015-03-18
DOI
10.1007/s11908-014-0459-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pentosan polysulfate treatment ameliorates motor function with increased serum soluble vascular cell adhesion molecule-1 in HTLV-1-associated neurologic disease
- (2014) Tatsufumi Nakamura et al. JOURNAL OF NEUROVIROLOGY
- An animal model of adult T-cell leukemia: humanized mice with HTLV-1-specific immunity
- (2013) K. Tezuka et al. BLOOD
- Therapeutic benefits of an oral vitamin B1 derivative for human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
- (2013) Jun-ichi Kira BMC Medicine
- Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy
- (2013) Hitoshi Ando et al. BRAIN
- Quality of life in patients with HTLV-I associated myelopathy/tropical spastic paraparesis
- (2012) José Vicente Pereira Martins et al. ARQUIVOS DE NEURO-PSIQUIATRIA
- Tropical spastic paraparesis and HTLV-1 associated myelopathy: Clinical, epidemiological, virological and therapeutic aspects
- (2012) A. Gessain et al. REVUE NEUROLOGIQUE
- HTLV-1 infection: what determines the risk of inflammatory disease?
- (2012) Sonja Tattermusch et al. TRENDS IN MICROBIOLOGY
- Epidemiological Aspects and World Distribution of HTLV-1 Infection
- (2012) Antoine Gessain et al. Frontiers in Microbiology
- Integrase Inhibitors Effective against Human T-Cell Leukemia Virus Type 1
- (2011) Muhammad Esa Seegulam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety of long-term treatment of HAM/TSP patients with valproic acid
- (2011) S. Olindo et al. BLOOD
- The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones
- (2011) N. A. Gillet et al. BLOOD
- Antiviral effect of raltegravir on HTLV-1 carriers
- (2011) A. Trevino et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Susceptibility of Primary HTLV-1 Isolates from Patients with HTLV-1-Associated Myelopathy to Reverse Transcriptase Inhibitors
- (2011) Beatrice Macchi et al. Viruses-Basel
- Evaluation of autonomic malfunction in HTLV-1 associated myelopathy (HAM)
- (2009) Nagato Kuriyama et al. AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL
- Human T-lymphotropic virus 1 neurologic disease
- (2008) Abelardo Araújo et al. Current Treatment Options in Neurology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started